Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Placebo to match Linaprazan glurate 50mg, Placebo to match Lansoprazole 30 mg, Linaprazan glurate, LANSOPRAZOLE
Lacuna Pharma Pty Ltd
Erosive esophagitis (EE) due to gastroesophageal reflux disease (GERD)
1 trial -
Placebo, Ebglyss 250 mg solution for injection in pre-filled syringe
Almirall, S.A.
Nummular Dermatitis
1 trial -
Placebo, Simvastatina NORMON 40 mg comprimidos recubiertos con película EFG
The George Institute
Fibrosis liber, chronic liver disease, alcoholic liver disease
1 trial -
Plasma exchange
Ultragenyx UK Limited
Acute Disseminated Encephalomyelitis
1 trial -
Platinum-based two drug chemotherapy (cisplatin/carboplatin + vinorelbine or cisplatin/carboplatin + pemetrexed regimen)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Non-small Cell Lung Cancer Stage IIIA
1 trial -
Plegridy 125 micrograms solution for injection in pre-filled pen, AVONEX 30 micrograms/0.5ml solution for injection in pre-filled pen., Plegridy 63 micrograms+94 micrograms solution for injection in pre-filled pen, AVONEX 30 micrograms/0.5 ml solution for injection.
Biogen
Relapsing Remitting Multiple Sclerosis (RRMS)
1 trial -
Pneumovax® 23 solution for injection in pre-filled syringe Pneumococcal Polysaccharide Vaccine, V110, Pneumococcal 21-valent Conjugate Vaccine
Merck Sharp and Dohme
Pneumococcal disease
1 trial -
PolyCore
Lacuna Pharma Pty Ltd
Congestive Heart Failure
1 trial -
Polyamide HD membrane
Sionna Therapeutics
End-stage Kidney Disease
1 trial -
Pozelimab
Regeneron UK Limited
CD55-deficient Protein-losing Enteropathy
1 trial -
Pozelimab
Regeneron UK Limited
Paroxysmal Nocturnal Hemoglobinuria
4 trials -
Pozelimab
Regeneron UK Limited
Age-related Macular Degeneration (AMD)
1 trial -
Pozelimab + Cemdisiran
Regeneron UK Limited
Generalized Myasthenia Gravis
1 trial -
Pramipexol Extended Release
Boehringer Ingelheim
Early Parkinson Disease (Early PD)
1 trial -
Pravastatina Kern Pharma 40 mg comprimidos EFG, Placebo Pravastatina
The George Institute
intrauterine growth restriction, preeclampsia
1 trial -
Pred Forte 10 mg/ml colirio en suspensión, Clobetasol propionate ophthalmic nanoemulsion, 0.05%
Laboratorios Tillomed Spain S.L.U
Inflammation and pain associated with ocular surgery
1 trial -
Prednisolon STADA® 5 mg Tabletten, Prednisolone placebo hard capsule and tablet, Normal Saline, Prednisolon STADA® 10 mg Tabletten, [1-13C]SODIUM ACETATE, Avalotcagene ontaparvovec
Lacuna Pharma Pty Ltd
Late-onset Ornithine transcarbamylase (OTC) deficiency
1 trial -
Prednisolon STADA® 5 mg Tabletten, Prednisolone placebo hard capsule, 10 mg, Prednisolone Placebo hard capsule, 5mg, Prednisolon STADA® 10 mg Tabletten, Pariglasgene brecaparvovec, Normal Saline
Lacuna Pharma Pty Ltd
Glycogen Storage Disease Type Ia (GSDIa)
1 trial -
Prevnar 13™
Merck KGaA, Darmstadt, Germany
Pneumococcal Infections
1 trial -
Privigen 100 mg/ml solution for infusion, Fortecortin® 2 mg Tabletten, Dexamethason 8 mg GALEN® Tabletten, Privigen 100 mg/ml solution for infusion, teclistamab, JNJ-64407564, Pomalidomide, Dexamethasone Tablets BP 2.0mg, Imnovid 3 mg hard capsules, Pomalidomide, Imnovid 1 mg hard capsules, Empliciti 400 mg powder for concentrate for solution for infusion., Empliciti 300 mg powder for concentrate for solution for infusion., Pomalidomide, VELCADE 3.5 mg powder for solution for injection, Privigen 100 mg/ml s
Janssen-Cilag International N.V.
Relapsed or Refractory Myeloma
1 trial -
Privigen 100 mg/ml solution for infusion, Gammanorm, 165 mg/ml, oplossing voor injectie, Octagam 10%, oplossing voor infusie, Nanogam 100 mg/ml oplossing voor infusie, Hizentra 200 mg/ml solution for subcutaneous injection, HyQvia 100 mg/ml solution for infusion for subcutaneous use, Cuvitru 200 mg/ml oplossing voor subcutane injectie, KIOVIG 100 mg/ml solution for infusion, CUTAQUIG 165 mg/mL, solution injectable, GAMMAGARD S/D 5,0 g, poeder en oplosmiddel voor oplossing voor infusie.
Disc Medicine
Primary antibody deficiency: - Unclassified antibody deficiency (unPAD) - IgA deficiency - Specific polysaccharide antibody deficiency (SPAD) - IgG subclass deficiency (IgSD) - Common variable immunodeficiency (CVID) - Agammaglobulinemia (X-linked or otherwise)
1 trial -
Progesterone
TherapeuticsMD
Secondary Amenorrhea
1 trial -
Progesterone
United Therapeutics Europe Ltd
Alcohol Dependence
1 trial -
Progesterone supplementation
Hospital Authority, Hong Kong
Assisted Reproductive Technology
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources